Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Unknown status
Raghu Nandan, M.D., Inc
Phase 2
1998-09-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating
patients who have stage IIIB or stage IV non-small cell lung cancer.
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
Terminated
National Cancer Institute (NCI)
Phase 1/Phase 2
1999-06-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Tretinoin may help hematologic cancer cells develop into normal
white blood cells.
PURPOSE: Phase I/II trial to study the effectiveness of arsenic trioxide with or without
tretinoin in treating patients who have hematologic cancer that has not responded to previous
therapy.
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
Terminated
Washington University School of Medicine
Phase 1/Phase 2
1999-06-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Tretinoin may help hematologic cancer cells develop into normal
white blood cells.
PURPOSE: Phase I/II trial to study the effectiveness of arsenic trioxide with or without
tretinoin in treating patients who have hematologic cancer that has not responded to previous
therapy.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
